-
What does ABBOTT VASCULAR INTERNATIONAL do?
- Abbott Vascular International specializes in developing and manufacturing innovative medical devices for cardiovascular treatments. The company focuses on advanced technologies in stent and balloon catheter systems to improve patient outcomes in various vascular conditions. Its commitment to research and development supports the delivery of high-quality healthcare solutions worldwide.
-
Company number
-
0886.537.933
-
Location
- Culliganlaan 2B Machelen (Brab.) 1831
-
Founding date
- Founded in 17-01-2007
-
Juridical situation
- Normale toestand
-
Juridical form
- Besloten Vennootschap
-
Type of enterprise
- Rechtspersoon
Very high risk
High risk
Average
Low risk
Very low risk
| Financial ratios | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Equity |
€
20.44M
7.63%
|
€
18.99M
14.85%
|
€
16.53M
14.44%
|
€
14.45M
|
| Turnover |
€
50.30M
5.36%
|
€
47.74M
-2.65%
|
€
49.04M
9.38%
|
€
44.83M
|
| Profit |
€
1.37M
-53.42%
|
€
2.94M
0.93%
|
€
2.91M
92.64%
|
€
1.51M
|
| EBITDA |
€
1.57M
-49.29%
|
€
3.10M
0.42%
|
€
3.09M
39.43%
|
€
2.21M
|
| Debt |
€
27.26M
11.26%
|
€
24.50M
-1.46%
|
€
24.86M
-9.89%
|
€
27.59M
|
| Cash |
€
378K
|
|||
| Employees |
92.20
-3.46%
|
95.50
12.22%
|
85.10
7.04%
|
79.50
|
Directors
All directorsActivities according to NACEBEL codes
Activities
VAT Activities
Social Security Activities
Publications 60
All publicationsSimilar companies
Show allFrequently asked questions
The VAT number of ABBOTT VASCULAR INTERNATIONAL is BE0886.537.933.
In 2023, ABBOTT VASCULAR INTERNATIONAL employed 92.20 full-time equivalents (FTE).
ABBOTT VASCULAR INTERNATIONAL was founded in 17-01-2007.
The official address of ABBOTT VASCULAR INTERNATIONAL is Culliganlaan 2B Machelen (Brab.) 1831 .
The juridical form of ABBOTT VASCULAR INTERNATIONAL is Besloten Vennootschap.
The legal situation of ABBOTT VASCULAR INTERNATIONAL is Normale toestand.
The annual revenue of ABBOTT VASCULAR INTERNATIONAL is €50,298,255.
Abbott Vascular International specializes in developing and manufacturing innovative medical devices for cardiovascular treatments. The company focuses on advanced technologies in stent and balloon catheter systems to improve patient outcomes in various vascular conditions. Its commitment to research and development supports the delivery of high-quality healthcare solutions worldwide.
Sources
Ready to start?
Find out the financial situation of potential customers, suppliers or business partners by consulting official information and key figures.
